Literature DB >> 14714555

Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.

G Rumpler1, B Becker, C Hafner, M McClelland, W Stolz, M Landthaler, R Schmitt, A Bosserhoff, T Vogt.   

Abstract

Currently, the scale and consistency of changes of gene expression profiles in models of melanoma progression are largely unknown. Therefore, we investigated siblings of cell lines or malignant melanomas (MM), which have been selected by nude mouse passages for (a). increased tumorigenicity (local ECM-independent growth), (b). metastatic potential, or (c). selected for increase invasiveness using the Boyden chamber. cDNA array analysis surveying more than 27.000 transcripts per cell line showed that 1.5-2.8% of all detectable transcripts were consistently differentially regulated during selection process in those models. Using array analysis, we identified 33 individual transcripts that exhibited significant differential hybridization paralleling the increased aggressiveness of the selected progeny. Because some of those genes could play a significant functional role in the progression of MM, we additionally proved their regulative pattern using Northern blotting. Among others, progressive overexpression of osteonectin/SPARC, a angiogenesis, was found in the selected offspring from all three experimental models and may therefore be considered as a potential marker for aggressive MM as well a promising therapeutic target. We further show that the selection of MM cells for increased ECM-independent local growth was accompanied by overexpresssion of macrophage migration inhibiting factor (MIF), an important modulator of both cell cycle progression and angiogenesis, and cathepsin Z, a novel member of the family of matrix degrading proteinases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14714555     DOI: 10.1111/j.0906-6705.2003.00082.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  18 in total

1.  A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling.

Authors:  Mee-Jung Han; Huan Wang; Lynn A Beer; Hsin-Yao Tang; Meenhard Herlyn; David W Speicher
Journal:  Proteomics       Date:  2010-11-17       Impact factor: 3.984

2.  RNA interference against SPARC promotes the growth of U-87MG human malignant glioma cells.

Authors:  Haiyan Liu; Yuanyuan Xu; Yun Chen; Haowen Zhang; Saijun Fan; Shuang Feng; Fenju Liu
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

3.  Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis.

Authors:  Rakshamani Tripathi; Leann S Fiore; Dana L Richards; Yuchen Yang; Jinpeng Liu; Chi Wang; Rina Plattner
Journal:  Sci Signal       Date:  2018-02-20       Impact factor: 8.192

4.  Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.

Authors:  María V Lopez; Patricia Blanco; Diego L Viale; Eduardo G Cafferata; Cecilia Carbone; David Gould; Yuti Chernajovsky; Osvaldo L Podhajcer
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

5.  Overexpression of cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Jian Wang; Leilei Chen; Yan Li; Xin-Yuan Guan
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

6.  Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.

Authors:  Katrina Kos; Steve Wong; Bee Tan; Anders Gummesson; Margareta Jernas; Niclas Franck; David Kerrigan; Fredrik H Nystrom; Lena M S Carlsson; Harpal S Randeva; Jonathan H Pinkney; John P H Wilding
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

7.  SPARC: a matricellular regulator of tumorigenesis.

Authors:  Shanna A Arnold; Rolf A Brekken
Journal:  J Cell Commun Signal       Date:  2009-10-07       Impact factor: 5.782

8.  Cathepsin X in serum from patients with colorectal cancer: relation to prognosis.

Authors:  Tjasa Vizin; Ib Jarle Christensen; Hans Jørgen Nielsen; Janko Kos
Journal:  Radiol Oncol       Date:  2012-07-24       Impact factor: 2.991

9.  Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.

Authors:  Byungwoo Ryu; Dave S Kim; Amena M Deluca; Rhoda M Alani
Journal:  PLoS One       Date:  2007-07-04       Impact factor: 3.240

10.  Melanoma-restricted genes.

Authors:  Ena Wang; Monica C Panelli; Katia Zavaglia; Susanna Mandruzzato; Nan Hu; Phil R Taylor; Barbara Seliger; Paola Zanovello; Ralph S Freedman; Francesco M Marincola
Journal:  J Transl Med       Date:  2004-10-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.